Hosted by The Jockey Club School of Public Health and Primary Care at The Chinese University of Hong Kong (CUHK), a seminar titled "Aspirin and the Prevention of Cancer and Other Chronic Diseases" was successfully conducted on 1 March 2024.
We were honoured to have welcomed Professor Andrew T. Chan, the Daniel K. Podolsky Professor of Medicine at Harvard Medical School and Professor of Immunology and Infectious Diseases at Harvard T. H. Chan School of Public Health. His insightful presentation delved into the potential use of Aspirin in reducing the risk of cardiovascular events and colorectal cancer, while also providing an outlook on prevention of cancer and other chronic diseases.
The seminar provided a valuable platform for researchers, academics, healthcare professionals, and industry practitioners to exchange trends, research findings, and best practices. The active engagement of the audience assured us that participants gained useful knowledge and practical insights from Professor Chan's presentation.
Our School will continue to foster knowledge transfer through the exchange with world-leading experts, aiming to contribute to the improvement in health for all.
Professor Andrew T. Chan delivered a presentation titled “Aspirin and the Prevention of Cancer and Other Chronic Diseases”
The seminar was moderated by Professor Martin Wong, Professor, The JC School of Public Health and Primary Care, CUHK
Participants actively engaged in the Q&A session and were inspired by the presentation delivered by Prof Andrew T. Chan
Prof Samuel Wong (right), Director; and Prof Martin Wong (left), Professor, from The JC School of Public Health and Primary Care, CUHK, presented a souvenir to Prof Andrew T. Chan (middle)
About the speaker
Professor Andrew T. Chan, MD, MPH is a gastroenterologist, the Daniel K. Podolsky Professor of Medicine at Harvard Medical School, Professor of Immunology and Infectious Diseases at Harvard T. H. Chan School of Public Health, Chief of the Clinical and Translational Epidemiology Unit at Massachusetts General Hospital, Director of Epidemiology at the MGH Cancer Center, and co-leader of the Cancer Epidemiology Program of the Dana-Farber Harvard Cancer Center. Through contributions ranging from clinical trials to population epidemiology, Dr. Chan’s research focuses on the role of aspirin, diet, lifestyle, and screening for prevention and treatment of gastrointestinal cancers through molecular approaches linked with epidemiologic data. He is supported as an Outstanding Investigator of the NCI and several awards from NCI, NIA, and NIDDK. He is a member of the American Society for Clinical Investigation and the Association of American Physicians and an American Cancer Society Clinical Research Professor.
About the moderator
Professor Martin C. S. Wong is a specialist in Family Medicine and a researcher in the field of cancer screening and prevention of chronic diseases. He has been the Co-Chairman of the Grant Review Board, Health and Medical Research Fund, the Health Bureau (HHB); member of the Research Council of HHB; Convener of the Advisory Group on Hong Kong Reference Framework for Care of Diabetes and Hypertension in Primary Care Settings; and the Editor-in-Chief of the Hong Kong Medical Journal. He has over 350 publications in peer-reviewed journals and ranked the top 0.07% in his research field by expertscape. His research work was published in international journals including Nature series, Lancet Hematology, JAMA Oncology, Gastroenterology, Gut, European Heart Journal, and European Urology.
In 2016, he was conferred as an Honorary Fellow by the Hong Kong Academy of Nursing to recognize his achievements in the profession and contributions to primary care. He was appointed as Fellows of various Academies, Royal Colleges and professional societies. He is currently taking adjunct appointments as Professor of the Peking Union Medical College in March 2019; Professor of Global Health by the Peking University, and Professor of Public Health in the Fudan University.
Comments